Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:14
|
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry
    Veselka, Josef
    Jensen, Morten Kvistholm
    Liebregts, Max
    Januska, Jaroslav
    Krejci, Jan
    Bartel, Thomas
    Dabrowski, Maciej
    Hansen, Peter Riis
    Almaas, Vibeke Marie
    Seggewiss, Hubert
    Horstkotte, Dieter
    Tomasov, Pavol
    Adlova, Radka
    Bundgaard, Henning
    Steggerda, Robbert
    ten Berg, Jurrien
    Faber, Lothar
    EUROPEAN HEART JOURNAL, 2016, 37 (19) : 1517 - 1523
  • [2] Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Jahnlova, Denisa
    Tomasov, Pavol
    Adlova, Radka
    Januska, Jaroslav
    Krejci, Jan
    Dabrowski, Maciej
    Veselka, Josef
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (03) : 650 - 655
  • [3] Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly
    Liebregts, Max
    Steggerda, Robbert C.
    Vriesendorp, Pieter A.
    van Velzen, Hannah
    Schinkel, Arend F. L.
    Willems, Rik
    van Cleemput, Johan
    van den Berg, Maarten P.
    Michels, Michelle
    ten Berg, Jurrien M.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (05) : 463 - 469
  • [4] Effect of Alcohol Dosage on Long-Term Outcomes After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
    Liebregts, Max
    Vriesendorp, Pieter A.
    Steggerda, Robbert C.
    Schinkel, Arend F. L.
    Balt, Jippe C.
    Ten Cate, Folkert J.
    Michels, Michelle
    Ten Berg, Jurrien M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (06) : 945 - 952
  • [5] Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Endorsement
    Liebregts, Max
    Vriesendorp, Pieter A.
    ten Berg, Jurrien M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 481 - 488
  • [6] Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
    Veselka, Josef
    Zemanek, David
    Jahnlova, Denisa
    Krejci, Jan
    Januska, Jaroslav
    Dabrowski, Maciej
    Bartel, Thomas
    Tomasov, Pavol
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (10) : 1245 - 1251
  • [7] Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
    Meng, Xiangbin
    Wang, Wen-yao
    Gao, Jun
    Zhang, Kuo
    Zheng, Jilin
    Wang, Jing-jia
    Liu, YuPeng
    Shao, Chunli
    Tang, Yi-Da
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation
    Veselka, Josef
    Liebregts, Max
    Cooper, Robert
    Faber, Lothar
    Januska, Jaroslav
    Kashtanov, Maksim
    Tesarkova, Klara Hulikova
    Hansen, Peter Riis
    Seggewiss, Hubert
    Shloydo, Eugene
    Popov, Kirill
    Hansvenclova, Eva
    Bonaventura, Jiri
    ten Berg, Jurrien
    Stables, Rodney Hilton
    Polakova, Eva
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (19) : 1910 - 1917
  • [9] Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy
    Liebregts, Max
    Faber, Lothar
    Jensen, Morten K.
    Vriesendorp, Pieter A.
    Januska, Jaroslav
    Krejci, Jan
    Hansen, Peter R.
    Seggewiss, Hubert
    Horstkotte, Dieter
    Adlova, Radka
    Bundgaard, Henning
    ten Berg, Jurrien M.
    Veselka, Josef
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (11) : 1135 - 1143
  • [10] Age-related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
    Batzner, Angelika
    Aicha, Diaa
    Pfeiffer, Barbara
    Neugebauer, Anna
    Seggewiss, Hubert
    ESC HEART FAILURE, 2022, 9 (01): : 327 - 336